
What We’re Reading: VA Health Care Fight; High Court Sides With States on PBMs; Ezogabine and ALS
A funding dispute over how to account for a Veterans Affairs (VA) health care program is stalling deal to fund the government for another year; the Supreme Court rules in a case involving states and pharmacy benefit managers (PBMs); the antiepileptic drug ezogabine lowered the pathologic excitability of cortical and spinal motor neuron cells, which have a role in amyotrophic lateral sclerosis (ALS).
VA Health Care Funding Dispute Stalling Government Funding Deal
A dispute over veterans’ health care is the final big hurdle to an agreement on a mammoth omnibus funding the government until October 1, 2021,
Supreme Court Rules States Can Regulate PBMs
The Supreme Court ruled unanimously that states can regulate pharmacy benefit managers (PBMs). Arkansas led the 45-state suit,
Ezogabine May Have Role in ALS-Related Neuron Activity
A recent study, reported in
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.